AI
MEDP icon

Atria Investments’s Medpace MEDP Stock Holding History

Atria Investments’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.71M Buy
5,647
+234
+4% +$120K 0.03% 576
2025
Q4 		$3.04M Buy
5,413
+1,198
+28% +$680K 0.03% 557
2025
Q3 		$2.17M Buy
4,215
+1,136
+37% +$496K 0.02% 691
2025
Q2 		$966K Buy
3,079
+221
+8% +$66.3K 0.01% 1054
2025
Q1 		$871K Buy
2,858
+297
+12% +$99.9K 0.01% 1054
2024
Q4 		$851K Sell
2,561
-849
-25% -$288K 0.01% 1064
2024
Q3 		$1.14M Sell
3,410
-1,373
-29% -$522K 0.01% 903
2024
Q2 		$1.97M Sell
4,783
-217
-4% -$85.9K 0.03% 648
2024
Q1 		$2.02M Sell
5,000
-45
-0.9% -$15.8K 0.03% 653
2023
Q4 		$1.55M Buy
5,045
+862
+21% +$233K 0.02% 702
2023
Q3 		$1.01M Buy
+4,183
New +$1.07M 0.02% 838
2018
Q4 		– Sell
-4,099
Closed -$246K – 971
2018
Q3 		$246K Buy
+4,099
New +$224K 0.01% 850
2018
Q1 		– Sell
-5,822
Closed -$211K – 899
2017
Q4 		$211K Buy
+5,822
New +$204K 0.01% 758

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Atria Investments's MEDP Position: Q1 2026 in Review

Atria Investments increased its Medpace (MEDP) stake by 4.3% in Q1 2026, buying an estimated $120K and bringing the position to 5,647 shares worth $2.71M. The position accounts for 0.03% of the portfolio, ranked #576.

Atria Investments first reported a position in MEDP in Q4 2017 and has held it in 13 quarters since. The position peaked at $3.04M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Atria Investments held 5,647 shares of Medpace worth $2.71M as of Q1 2026.
  • Atria Investments bought 234 Medpace shares in Q1 2026, an estimated $120K.
  • Medpace made up 0.03% of Atria Investments's portfolio in Q1 2026, its #576 holding.
  • Atria Investments first reported a position in Medpace in Q4 2017 and has held it in 13 quarters since.
  • Atria Investments's Medpace position peaked at $3.04M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.